Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)
NCT07681778
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Leber Congenital Amaurosis
Leber Congenital Amaurosis (LCA)
Interventions
DRUG:
OPGx-RDH12
Sponsor
Opus Genetics, Inc